Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnaldo Caruso

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Ebiomedicine|November 6, 2022
Endothelial cells are major players in SARS-CoV-2-related acute respiratory distress syndromeFrancesca Caccuri, Arnaldo Caruso
Vaccines|February 26, 2022
The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?Maria Antonia De Francesco, Arnaldo Caruso
The New Microbiologica|October 6, 2016
HIV-1 infection, microenvironment and endothelial cell dysfunctionPietro Mazzuca, Arnaldo Caruso, Francesca Caccuri
Cancers|June 2, 2021
Viral Proteins as Emerging Cancer TherapeuticsEkta Manocha, Arnaldo Caruso, Francesca Caccuri
Blood|January 17, 2016
A lymphomagenic role for HIV beyond immune suppression?Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, et al.
The Pediatric Infectious Disease Journal|April 13, 2021
Possible Impact of Severe Acute Respiratory Syndrome Coronavirus-2 Control Measures in Reducing Colonization by Gram-negative Bacteria and Candida spp. in a Neonatal Intensive Care UnitRamona Pezzotta, Maria Antonia De Francesco, Arnaldo Caruso
The New Microbiologica|April 13, 2006
Functions of the HIV-1 matrix protein p17Simona Fiorentini, Elena Marini, Sonia Caracciolo, et al.
Infection Control and Hospital Epidemiology|September 23, 2020
May we learn a useful lesson from prevention rules against severe acute respiratory coronavirus virus 2 (SARS-CoV-2)?Silvia Corbellini, Maria Antonia De Francesco, Arnaldo Caruso
Current Drug Targets|August 26, 2015
HIV-1 Matrix Protein p17 and its ReceptorsFrancesca Caccuri, Stefania Marsico, Simona Fiorentini, et al.
Emerging Microbes & Infections|June 7, 2021
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variantsAlberto Zani, Francesca Caccuri, Serena Messali, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Ebiomedicine|November 6, 2022
Endothelial cells are major players in SARS-CoV-2-related acute respiratory distress syndromeFrancesca Caccuri, Arnaldo Caruso
Vaccines|February 26, 2022
The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?Maria Antonia De Francesco, Arnaldo Caruso
The New Microbiologica|October 6, 2016
HIV-1 infection, microenvironment and endothelial cell dysfunctionPietro Mazzuca, Arnaldo Caruso, Francesca Caccuri
Cancers|June 2, 2021
Viral Proteins as Emerging Cancer TherapeuticsEkta Manocha, Arnaldo Caruso, Francesca Caccuri
Blood|January 17, 2016
A lymphomagenic role for HIV beyond immune suppression?Riccardo Dolcetti, Annunziata Gloghini, Arnaldo Caruso, et al.
The Pediatric Infectious Disease Journal|April 13, 2021
Possible Impact of Severe Acute Respiratory Syndrome Coronavirus-2 Control Measures in Reducing Colonization by Gram-negative Bacteria and Candida spp. in a Neonatal Intensive Care UnitRamona Pezzotta, Maria Antonia De Francesco, Arnaldo Caruso
The New Microbiologica|April 13, 2006
Functions of the HIV-1 matrix protein p17Simona Fiorentini, Elena Marini, Sonia Caracciolo, et al.
Infection Control and Hospital Epidemiology|September 23, 2020
May we learn a useful lesson from prevention rules against severe acute respiratory coronavirus virus 2 (SARS-CoV-2)?Silvia Corbellini, Maria Antonia De Francesco, Arnaldo Caruso
Current Drug Targets|August 26, 2015
HIV-1 Matrix Protein p17 and its ReceptorsFrancesca Caccuri, Stefania Marsico, Simona Fiorentini, et al.
Emerging Microbes & Infections|June 7, 2021
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variantsAlberto Zani, Francesca Caccuri, Serena Messali, et al.
Pageof 22